THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Gli articoli più letti nelle ultime tre settimane

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):267-77
Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles
Shokeen M., Fettig N. M., Rossin R.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 December;52(4):430-40
MIBG for diagnosis and therapy of medullay thyroid carcinoma: is there still a role?
Castellani M. R., Seregni E., Maccauro M., Chiesa C., Aliberti G., Orunesu E., Bombardieri E.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):229-34
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach
Luca GIOVANELLA *, Lorenzo SCAPPATICCIO

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):278-83
The effects of androgen deprivation therapy on fluoromethylcholine uptake in prostate cancer patients undergoing neoadjuvant treatment
Laura EVANGELISTA *, Fabio ZATTONI, Andrea GUTTILLA, Umberto BASSO, Filiberto ZATTONI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49
Molecular imaging of bone metastases using tumor-targeted tracers
Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):227-8
Radioiodine dosimetry in advanced thyroid cancer
Luca GIOVANELLA *, Michael LASSMANN

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):323-38
Machine learning for radiomics-based multimodality and multiparametric modeling
Lise WEI, Sarah OSMAN, Mathieu HATT, Issam EL NAQA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):321-2
Radiomics in nuclear medicine and hybrid imaging: current standings on clinical applicability
Patrick VEIT-HAIBACH *, Issam EL NAQA, Dimitris VISVIKIS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):347-54
Are radiomics ready for clinical prime-time in PET/CT imaging?
Catherine CHEZE LE REST *, Roland HUSTINX

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):235-52
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Manuel WEBER, Ina BINSE, James NAGARAJAH, Andreas BOCKISCH, Ken HERRMANN, Walter JENTZEN *